Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2011 1
2013 1
2014 2
2015 8
2016 2
2017 6
2018 1
2019 2
2020 9
2021 10
2022 8
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.
Neldeborg S, Soerensen JF, Møller CT, Bill M, Gao Z, Bak RO, Holm K, Sorensen B, Nyegaard M, Luo Y, Hokland P, Stougaard M, Ludvigsen M, Holm CK. Neldeborg S, et al. Among authors: ludvigsen m. Leukemia. 2023 Sep;37(9):1792-1801. doi: 10.1038/s41375-023-01950-9. Epub 2023 Jul 18. Leukemia. 2023. PMID: 37464068 Free PMC article.
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder.
Hybel TE, Vase MØ, Maksten EF, Enemark MB, Lauridsen KL, Hamilton-Dutoit S, Andersen C, Møller MB, Sørensen SS, Jespersen B, Kampmann J, d'Amore F, Ludvigsen M. Hybel TE, et al. Among authors: ludvigsen m. Acta Oncol. 2021 Dec;60(12):1637-1642. doi: 10.1080/0284186X.2021.1973093. Epub 2021 Sep 2. Acta Oncol. 2021. PMID: 34474636 No abstract available.
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Hybel TE, Vase MØ, Lauridsen KL, Enemark MB, Møller MB, Pedersen C, Pedersen G, Hamilton-Dutoit S, Obel N, Schade Larsen C, d'Amore F, Ludvigsen M. Hybel TE, et al. Among authors: ludvigsen m. Leuk Lymphoma. 2022 Jun;63(6):1479-1483. doi: 10.1080/10428194.2021.2023741. Epub 2022 Jan 12. Leuk Lymphoma. 2022. PMID: 35019824 No abstract available.
Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma.
Vajavaara H, Ekeblad F, Holte H, Jorgensen J, Leivonen SK, Berglund M, Kamper P, Moller HJ, D'Amore F, Molin D, Enblad G, Ludvigsen M, Glimelius I, Leppa S. Vajavaara H, et al. Among authors: ludvigsen m. Haematologica. 2021 Sep 1;106(9):2502-2506. doi: 10.3324/haematol.2020.278182. Haematologica. 2021. PMID: 33764002 Free PMC article. No abstract available.
53 results